June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Segmented Swept Source OCT Angiography Assessment of the Foveal Avascular Zone Ratio in Ultra Wide-Field Imaged Non-Proliferative and Proliferative Diabetic Retinopathy: New Biomarker of Prognosis
Author Affiliations & Notes
  • Francesco Stringa
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
  • Emmanouil Tsamis
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
    Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
  • Soon Ch'ng
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
  • Goncalo Bento
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
  • Yvonne D'Souza
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
  • Assad Jalil
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
  • Paulo Eduardo Stanga
    Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester Clinical Research Facility and Manchester Royal Eye Hospital, Manchester Academic Health Science Centre, Central Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom
    Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
  • Footnotes
    Commercial Relationships   Francesco Stringa, None; Emmanouil Tsamis, None; Soon Ch'ng, None; Goncalo Bento, None; Yvonne D'Souza, None; Assad Jalil, None; Paulo Eduardo Stanga, Optos (C), Optos (F), Optos (R), Topcon Corporation (C), Topcon Corporation (F), Topcon Corporation (R)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1665. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Francesco Stringa, Emmanouil Tsamis, Soon Ch'ng, Goncalo Bento, Yvonne D'Souza, Assad Jalil, Paulo Eduardo Stanga; Segmented Swept Source OCT Angiography Assessment of the Foveal Avascular Zone Ratio in Ultra Wide-Field Imaged Non-Proliferative and Proliferative Diabetic Retinopathy: New Biomarker of Prognosis. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1665.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Segmented Swept-Source OCT Angiography (SS-OCTA) imaging of the foveal avascular zone (FAZ) and the parafoveal vasculature shows microvascular changes that can be correlated with the severity of diabetic retinopathy (DR). We aim to assess whether alterations in the parafoveal capillary plexuses can be interpreted as a clinical biomarker of disease progression.

Methods : Observational and retrospective study of diabetic patients diagnosed with Non-Proliferative (NPDR) and Proliferative (PDR) DR between January and October 2016. All eyes were imaged on Optos California® (Optos®, UK) and the retinopathy classified by two independent observers into three groups: mild/moderate NPDR, severe NPDR and PDR. SS-OCTA (Triton Plus®, Topcon Corp., Japan) images were acquired using the 6 mm x 6 mm fovea-centred cubes scanning protocol. Surface Area (SA) was measured using the Topcon IMAGEnet® (version 1.19) proprietary software after automated segmentation of the FAZ into superficial vascular (SVP) (SVP-FAZ) and deep vascular plexus (DVP) (DVP-FAZ). Eyes with Clinically Significant Macular Oedema (CSMO) and with previous panretinal photocoagulation (PRP) were excluded. The difference and ratio between SAs in SVP-FAZ and DVP-FAZ in each group were analysed.

Results : Five (PRP) and ten (CSMO) eyes were not included in the statistical analysis. Imaging results from seventy-four eyes (36 patients, 15 females and 21 males, mean age was 60.3 years (±11.65, range 35-83)) were included in this study. In all eyes, the SA of DVP-FAZ was larger than that of SVP-FAZ. Mild/moderate NPDR graded eyes showed the smallest SA of FAZ in both DVP and SVP (p<0.01), whereas PDR eyes showed the largest FAZ area in both plexuses (p<0.01). The ratio of SAs of SVP-FAZ over DVP-FAZ (rFAZ) was significantly lower in severe NPDR eyes vs. mild/moderate NPDR and PDR eyes (p<0.01).

Conclusions : The SA of FAZ in both plexuses is correlated with DR severity, increasing with severity of retinopathy. Capillary rarefaction in DVP compared to that in SVP is more evident in severe NPDR than in the other groups. The enlargement of SA of DVP-FAZ may indicate further enlargement of the SA of SVP-FAZ and progression to PDR. Therefore rFAZ could serve as a prognostic tool for the monitoring of DR.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×